TOKYO – October 31, 2026 -- Happiness shows the strongest parent-child link among three well-being measures in Japan, with a rank-rank slope of 0.25, according to Keio University researchers. Self-reported general health followed at 0.22, and mental health was weakest at 0.13. All three associations were statistically significant.

The study by Kayoko Ishii, Zhi-xiao Jia and Isamu Yamamoto appeared in the journal Review of Economics of the Household. It uses data from the Japan Household Panel Survey, run in association with Keio's Panel Data Research Center.

Stockholm – October 30, 2026 -- Eisai will present five years of Clarity AD data on lecanemab (Leqembi) at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, November 16-19, 2026, according to its partner BioArctic AB (Nasdaq Stockholm: BIOA B). The dataset spans the core and long-term extension phases and is one of the longest follow-up sets reported to date for an approved anti-amyloid Alzheimer's therapy.

TAIPEI – October 30, 2026 -- Hon Hai Technology Group (Foxconn) (TWSE: 2317) unveiled three new reference electric vehicles, lifting its EV range to 12 models and extending its contract design and manufacturing service (CDMS) offer into Japan's kei-class trucks.

The MODEL A+ SUV, MODEL K+ SUV and MODEL K compact truck target under-penetrated markets. Foxconn is pitching them as cost-competitive options built on flexible design platforms for automotive clients.

DALLAS – October 29, 2026 -- Nanoscope Therapeutics will field four executives across six sessions at Advanced Therapies USA 2026 in Boston on November 4-5, as its optogenetic gene therapy MOGENRY (sonpiretigene isteparvovec; MCO-010) awaits decisions from the U.S. FDA and Japan's PMDA. The conference, held at the Hynes Convention Center, brings together cell and gene therapy developers, manufacturers, investors and commercial leaders.

TOKYO – October 29, 2026 -- The Global Health Innovative Technology (GHIT) Fund has committed about JPY 1.06 billion (USD 6.8 million) to nine R&D projects covering drugs, vaccines and diagnostics for malaria, neglected tropical diseases (NTDs) and emerging infectious diseases such as Ebola.

TOKYO – October 29, 2026 -- Australia's National Transport Research Organisation (NTRO) has bought a 15-seater electric autonomous bus from Japan's TIER IV, opening demonstrations and in-service trials to transport agencies and operators across Australia and New Zealand.

Munich/Tokyo – October 29, 2026 -- Proxima Fusion and Japan's Fujikura signed a memorandum of understanding to explore industrial-scale production of high-temperature superconductor (HTS) tape in Germany, anchored by planned demand of 60,000 kilometers from Proxima's own fusion projects. The MoU was signed in Tokyo in the presence of German Chancellor Friedrich Merz and Japanese Prime Minister Sanae Takaichi.

San Francisco – October 28, 2026 -- Doppel, a social engineering defense (SED) platform vendor, has been named to the 2026-2027 Fortune Cyber 60 list for the second consecutive year, as it passes 300 employees and expands into Japan and Toronto.

ATSUGI – October 28, 2026 -- Sony Semiconductor Solutions Corporation announced the LYTIA 720, an approximately 50-effective-megapixel CMOS image sensor for mobile devices that cuts random noise in dark environments by about 50% compared with a conventional product.

TOKYO – October 28, 2026 -- transcosmos has partnered with Tokyo-based Metaverse Creators Inc. to distribute VRChat 3D content to overseas buyers through Geek Jack, its cross-border e-commerce platform for entertainment products.

Avatars, outfits, hairstyles, accessories and other items planned, produced and sold by Metaverse Creators will be added to Geek Jack gradually. Metaverse Creators is led by CEO Kazuo Wakamiya.